This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 26 Oct 2015  |  Asia Pacific  |  Market Research

    Asia-Pacific Regulations Driving Innovation in Healthcare

    Innovative Public-Private Initiatives Attracting Investment in Research & Development

    The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...

    $1,500.00
  2. 22 Oct 2015  |  North America  |  Market Research

    Analysis of the US Clinical Laboratories Market

    Decentralization will Significantly Increase Retail Setting Test Volume by 2017

    This research service evaluates the US clinical laboratories market. The analysis provides extensive understanding of test distribution in independent laboratories (reference and specialized), physician office laboratories, hospital-based labs, and others including retail clinics and mobile diagnostic centers. The study covers the potential impact ...

    $4,950.00
  3. 30 Sep 2015  |  Europe  |  Market Research

    Profiling the Top Mergers and Acquisition Within Medical Devices Space

    Changing Healthcare Dynamics Driving the M&A

    The landscape of healthcare is rapidly changing worldwide as governments are reducing healthcare spending through means such as reimbursement cuts. The medical devices market bears the direct brunt of these measures. To overcome this, medical device companies are involved in active mergers and acquisitions (M&A). The study analyses the key factors ...

    $1,500.00
  4. 30 Sep 2015  |  Global  |  Market Research

    A Product and Pipeline Analysis of the Global Immunoglobulin Market

    Trends in Communicable and Non-Communicable Diseases Drug Pipeline

    Immunoglobulin therapies are life-saving medicines that have been in use for more than 60 years. They provide the patient with a variety of antibodies and are often used as a last line of defense in many severe inflammatory diseases. In some conditions, they are life-saving. However, immunoglobulin therapies are expensive. Despite this, global dem...

    $4,950.00
  5. 29 Sep 2015  |  Europe  |  Market Research

    Analysis of the European Digital and Computed Radiography Markets

    Workflow Integration Provides Potential for Growth

    This research service presents an analysis of the digital and computed radiography markets in Europe. It also provides an in-depth analysis of the market and discusses market characteristics such as size, revenue forecasts, drivers, restraints, market penetration and market attractiveness for both the digital radiography (DR) and the computed rad...

    $4,950.00
  6. 29 Sep 2015  |  Global  |  Market Research

    Insights for CFOs betting on Intellectual Property

    Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and greater convenience to patients. This research service evaluates ...

    $4,950.00
  7. 29 Sep 2015  |  Global  |  Market Research

    Global Review of Intellectual Property (IP) Funds

    Big pharma companies increasingly consider outsourcing manufacturing to CMOs as a strategic move because of the uncomplicated, timely, and cost-effective services CMOs provide as well as the fact that companes can then focus on their core competencies. This study provides market overview, market engineering measurements, revenue forecasts, competit...

    $4,950.00
  8. 28 Sep 2015  |  Asia Pacific  |  Market Research

    End-User Perspectives on the SEA RIS/ PACS Market

    Next-generation Imaging IT Needs Will Focus on Interoperability

    Picture archiving communication systems (PACS) were a real game changer 3 decades ago when, in combination with radiology information systems (RIS), they enabled rapid digitalization of medical imaging data. Today, Southeast Asia again stands at the brink of transformation as RIS PACS enter their second or third generation of deployment. In an effo...

    $4,950.00
  9. 28 Sep 2015  |  Global  |  Market Research

    Vital Signs The Analyst's Perspective - August 2015 Issue

    This issue of Vital Signs discusses the FDA's clearnace of the first 3-D printed prescription drug, Illumina's formation of consumer genomics company Helix, Response Genetics' acquisition of Cancer Genetics, and Roche's acquisition of GeneWEAVE.

    $450.00
  10. 21 Sep 2015  |  North America  |  Market Research

    Vital Signs - Review of AHRA 2015: Key Conference Takeaways and Gadolinium Based MR Contrast Agents Safety Issues

    Overview of Top Themes from the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA)

    A record-high attendance of 1,000 radiology directors and managers convened to the 2015 Annual Meeting of the Association for Medical Imaging Management (AHRA 2015) held this year in Las Vegas. Radiology is going through interesting times indeed. Under the coordinated care paradigm that is gradually emerging in the U.S., and with all the changes th...

    $450.00